Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: pH Method Development for API – V 2.0

Posted on By

Analytical Method Development: pH Method Development for API – V 2.0

SOP for pH Method Development of Active Pharmaceutical Ingredients in AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/042/2025
Supersedes SOP/AMD/042/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for developing and validating pH measurement methods for Active Pharmaceutical Ingredients (APIs) in the Analytical Method

Development (AMD) department. It ensures accurate, reproducible, and regulatory-compliant pH determination that supports preformulation, stability, and quality assessment activities.

2. Scope

This SOP applies to pH method development and optimization of all APIs handled in the AMD laboratory, including new chemical entities (NCEs), generic actives, and intermediates requiring aqueous or partially aqueous pH measurement.

3. Responsibilities

  • Analytical Scientist: Conducts method development, documents procedures and performs validation.
  • Reviewer: Verifies method accuracy, precision, linearity, and robustness results.
  • QA: Reviews method validation report and ensures alignment with ICH guidelines.
  • Head – AMD: Approves finalized method and validation report for regulatory filing.

See also  Analytical Method Development: Preparation of Method Development Report - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring all pH methods developed for APIs are scientifically justified, validated, and traceable as per applicable GMP and ICH requirements.

5. Procedure

5.1 Pre-Method Considerations

  1. Obtain API solubility and dissociation profile from literature or preformulation data.
  2. Select appropriate solvent system:
    • Water or buffer (0.1N HCl, 0.1N NaOH, phosphate buffers)
    • Maintain ionic strength where necessary
  3. Use Annexure-1: pH Method Development Plan to document method rationale and objectives.

5.2 Preparation of Sample Solutions

  1. Weigh accurate quantity of API (e.g., 100 mg) into a beaker.
  2. Dissolve in required volume of solvent or buffer (e.g., 100 mL water or pH 7.0 phosphate buffer).
  3. Filter using Whatman No. 1 filter paper if needed to remove insoluble matter.
  4. Label all test samples clearly with strength, solvent, and API name.

5.3 Instrument Preparation

  1. Ensure pH meter calibration with standard buffers (pH 4.01, 7.00, and 9.21).
  2. Document calibration in Annexure-2: pH Meter Calibration Log.
  3. Check electrode condition and refill electrolyte (if applicable).

5.4 pH Measurement Procedure

  1. Transfer approx. 50 mL of prepared API solution to a clean 100 mL beaker.
  2. Immerse electrode in solution, ensuring no air bubbles around the bulb.
  3. Allow reading to stabilize for 30–60 seconds before recording.
  4. Record temperature of measurement (e.g., 25°C ± 2°C).
  5. Rinse electrode with deionized water between samples.
  6. Perform measurement in duplicate and report average.
See also  Analytical Method Development: Literature Review for Method Development - V 2.0

5.5 Method Optimization Parameters

  1. Assess stability of pH over 2 hours (interval: 0, 30, 60, 120 minutes).
  2. Determine pH in different solvent systems to simulate degradation or solubility behavior.
  3. Evaluate temperature influence by performing trials at 20°C, 25°C, and 30°C.
  4. Document data in Annexure-3: pH Optimization Worksheet.

5.6 Method Validation Criteria

  1. Linearity: Prepare known acidic/basic dilutions and assess pH response.
  2. Precision: Perform repeatability (6 readings from same analyst) and intermediate precision (2 analysts, 2 days).
  3. Accuracy: Compare with expected theoretical pKa or known reference value.
  4. Robustness: Alter buffer strength, temperature, and assess effect on pH.
  5. Document validation results in Annexure-4: pH Method Validation Report.

5.7 Final Method Documentation

  1. Consolidate method SOP including:
    • Sample preparation
    • Solvent system
    • Electrode care
    • Acceptance criteria
  2. Submit method and validation report to QA and retain approved copy in DMS.

6. Abbreviations

  • AMD: Analytical Method Development
  • API: Active Pharmaceutical Ingredient
  • ICH: International Council for Harmonisation
  • DMS: Document Management System
  • QA: Quality Assurance

7. Documents

  1. pH Method Development Plan – Annexure-1
  2. pH Meter Calibration Log – Annexure-2
  3. pH Optimization Worksheet – Annexure-3
  4. pH Method Validation Report – Annexure-4
See also  Analytical Method Development: Change Control for Developed Methods - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <791> – pH
  • 21 CFR Part 211 – Subpart I: Laboratory Controls
  • Ph. Eur., JP – General Notices on pH Measurement

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: pH Method Development Plan

API Solvent System Expected Range Prepared By
API-X 0.1N HCl 2.5–3.5 Ajay Mehra

Annexure-2: pH Meter Calibration Log

Date Buffer Used Reading Calibrated By
01/05/2025 pH 4.01 4.02 Sunita Reddy
01/05/2025 pH 7.00 7.01 Sunita Reddy

Annexure-3: pH Optimization Worksheet

Time (min) pH Reading Temperature (°C) Remarks
0 3.10 25.1 Stable
60 3.08 25.0 Negligible change

Annexure-4: pH Method Validation Report

Parameter Acceptance Criteria Result Status
Precision RSD ≤ 1% 0.45% Pass
Robustness pH change ≤ ±0.1 ±0.06 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included method validation and optimization sections Regulatory Filing Requirement
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Intermediate Moisture Check using IR Balance – V 2.0
Next Post: Biosimilars: SOP for Documentation of Clone Selection and Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version